Literature DB >> 2819882

Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.

M Eghbali, C Santoro, W Paredes, E L Gardner, R S Zukin.   

Abstract

In order to gain insight into a possible modulatory role for mu, delta, and kappa opioid receptors of the nigrostriatal dopaminergic pathway, we investigated the topographical organization of the receptors with respect to pre- and postsynaptic membranes. Dopaminergic terminals projecting from the substantia nigra to the corpus striatum were destroyed by unilateral injection of 6-hydroxydopamine into the substantia nigra. Quantitative receptor assays using highly specific radioligands were used to measure the density of striatal mu, delta, and kappa receptors before and after denervation. Denervation caused a 34 +/- 2% loss of striatal mu receptors and a 32 +/- 1% loss of striatal delta receptors on the lesioned side of the brain; in contrast, kappa receptors did not change significantly in density. Quantitative in vitro autoradiography was used to visualize the neuroanatomical pattern of receptors on lesioned and nonlesioned sides of the brain under the light microscope. Loss of mu receptors in striatal patches was striking in the ventrolateral areas of the striatum, whereas the most notable loss of delta receptors was found in the central striatum. Other brain areas did not differ significantly in mu receptor density between the lesioned and nonlesioned sides, as determined by autoradiography. These findings suggest that a high percentage of mu and delta receptors in the striatum are located on the nigrostriatal dopaminergic terminals and support the concept of a modulatory role for mu and delta opioid peptides in the nigrostriatal dopaminergic pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819882      PMCID: PMC299123          DOI: 10.1073/pnas.84.18.6582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.

Authors:  H Pollard; C Llorens; J C Schwartz; C Gros; F Dray
Journal:  Brain Res       Date:  1978-08-04       Impact factor: 3.252

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Striatal opiate receptors: pre- and postsynaptic localization.

Authors:  L C Murrin; J T Coyle; M J Kuhar
Journal:  Life Sci       Date:  1980-09-29       Impact factor: 5.037

4.  Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions.

Authors:  E L Gardner; R S Zukin; M H Makman
Journal:  Brain Res       Date:  1980-07-21       Impact factor: 3.252

5.  Morphine and delta-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus.

Authors:  M F Chesselet; A Chéramy; T D Reisine; J Glowinski
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

6.  Striatal lesions with kainic acid: neurochemical characteristics.

Authors:  R Schwarcz; J T Coyle
Journal:  Brain Res       Date:  1977-05-27       Impact factor: 3.252

7.  Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality.

Authors:  M Herkenham; C B Pert
Journal:  J Neurosci       Date:  1982-08       Impact factor: 6.167

8.  Immunocytochemical localization of enkephalin in the neostriatum of rat brain: a light and electron microscopic study.

Authors:  V M Pickel; K K Sumal; S C Beckley; R J Miller; D J Reis
Journal:  J Comp Neurol       Date:  1980-02-15       Impact factor: 3.215

9.  Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Authors:  H W Kosterlitz; S J Paterson; L E Robson
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

10.  Effects of d-amphetamine and naloxone on brain stimulation reward.

Authors:  R U Esposito; W Perry; C Kornetsky
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  9 in total

1.  Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.

Authors:  T P Piepponen; J A Mikkola; M Ruotsalainen; D Jonker; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.

Authors:  V Daugé; P Rossignol; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Opioid receptors in midbrain dopaminergic regions of the rat. II. Kappa and delta receptor autoradiography.

Authors:  S G Speciale; K F Manaye; M Sadeq; D C German
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Opioid receptors in midbrain dopaminergic regions of the rat. I. Mu receptor autoradiography.

Authors:  D C German; S G Speciale; K F Manaye; M Sadeq
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.

Authors:  C Marin; T M Engber; P Chaudhuri; A Peppe; T N Chase
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  Opioid binding in the rostral hypothalamus is reduced following lesion of the ventral noradrenergic tract in female rats.

Authors:  R G Dyer; N Parvizi; S Hollingsworth; S Mansfield; R P Heavens; R J Bicknell; D J Sirinathsinghji
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

7.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

8.  Increased dopamine receptor sensitivity in the rat following acute administration of sufentanil, U50,488H and D-Ala2-D-Leu5-enkephalin.

Authors:  K F Rooney; R A Armstrong; R D Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

9.  Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Zaida Diaz-Cabiale; Alicia Rivera; Luca Ferraro; Sergio Tanganelli; Alexander O Tarakanov; Pere Garriga; José Angel Narváez; Francisco Ciruela; Michele Guescini; Luigi F Agnati
Journal:  Front Physiol       Date:  2012-06-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.